// App-Quantinova.ai

P701 : COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS

Researchers

Presenter

  • Susanne Sauele

Principal Investigators

  • Nicola Evans

  • Franck E. Nicolini

  • Ekaterina Chelysheva

  • Delphine Ra

  • Fausto Castagnetti

  • Simone Claudiani

  • Raquel Rodrigues

  • Chung Kok

  • Timothy Hughes

Medical Centers

  • International CML Foundation,London,Royaume-uni

  • International CML Foundation,London,Regno Unito

  • Hematology department,Centre Léon Bérard and INSERM1052,Lyon,Frankreich

  • International CML Foundation,London,United Kingdom

  • Hammersmith Hospital,Imperial College Healthcare NHS Trust,London,Vereinigtes Königreich

  • Departamento de Hematologia,Instituto Português de Oncologia de Lisboa - IPO,Lisbon,Portugal

  • Hematology department,Centre Léon Bérard and INSERM105

  • National Research Center for Hematology, Moscow, Russia

  • Hematology department,Saint-Louis Hospital ,Paris,Frankreich

  • Hematology department,Centre Léon Bérard and INSERM1052,Lyon,France

  • Department of Haematology,Hammersmith Hospital, Imperial College Healthcar

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • III. Med. Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany

  • National Research Center for Hematology, Moscow, Russia

  • Cancer Program, Precision Medicine Theme,South Australian Health and Medical Research Institute,Adelaide,Australia

  • III. Med. Klinik,Medizini

  • Dermatology Department, Saint Louis Hospital, Paris, France

  • National Research Center for Hematology, Moscow, Russia

  • III. Med. Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany

  • International CML Foundation,London,Regno Unito

  • III. Med. Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany

  • International CML Foundation,London,Verenigd Koninkrijk

  • Hematology department,Saint-Louis Hospital ,Paris,Frankreich

  • Cancer Program, Precision Medicine Theme,South Australian Health and Medical Research Institute,Adelaide,Australia

  • Departamento de Hematologia,Instituto Português de Oncologia de Lisboa - IPO,Lisbon,Portugal

  • International CML Foundation,London,Соедин

  • Hematology department,Centre Léon Bérard and INSERM1052,Lyon,France

  • Surgery department,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Istituto di Ematologia 'Seràgnoli',IRCCS Azienda Ospedaliero-Universitaria di Bologna,Bologna,Italien

  • International CML Foundation,London,Verenigd Koninkrijk

  • Istituto di Ematologia 'Seràgnoli',IRCCS Azienda Ospedaliero-Universitaria di Bologna,Bologna,Italien

  • Cancer Program, Precision Medicine Theme,South Australian Health and Medical Research Institute,Adelaide,Australia

  • Pre

  • Dermatology Department, Saint Louis Hospital, Paris, France

  • III. Med. Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany

  • Departamento de Hematologi

  • National Research Center for Hematology, Moscow, Russia

  • Istituto di Ematologia 'Seràgnoli',IRCCS Azienda Ospedaliero-Universitaria di Bologna,Bologna,Italien

  • Department of Haematology,Hammersmith Hospital, Imperial College Healthcare NHS Trust,London,Royaume-uni

  • Istituto di Ematologia 'Seràgnoli',IRCCS Azienda Ospedaliero-Universitaria di Bologna,Bologna,Italien

  • Hematology department,Saint-Louis Hospital ,Paris,Frankreich

Locations

  • Germany

  • United Kingdom

  • France

  • United States

  • Russia

  • Senegal

  • Italy

  • Portugal

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Coronavirus disease

Biomarkers

  • Breakpoint Cluster Region

  • Abelson murine leukemia viral oncogene homolog

  • Cluster of Differentiation 206

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A